Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Aprea Therapeutics Inc., 3 years.
Aprea Therapeutics Inc.
Director
Oncolytics Biotech Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Aprea Therapeutics Inc. | Grant or award | +3,135 | — | — |
| Feb 12, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +40,000 | $0.85 | $34,000 |
| Feb 11, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +60,000 | $0.83 | $49,800 |
| Jan 16, 2026 | Oncolytics Biotech Inc. | Open-market purchase | +100,000 | $1.04 | $104,000 |
| Jun 5, 2025 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Oct 11, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +10,000 | $2.68 | $26,800 |
| Jun 20, 2024 | Aprea Therapeutics Inc. | Grant or award | +1,045 | — | — |
| Mar 13, 2024 | Aprea Therapeutics Inc. | Open-market purchase | +6,860 | $7.29 | $50,009 |
| Aug 23, 2023 | Aprea Therapeutics Inc. | Grant or award | +500 | — | — |
| Jun 7, 2023 | Aprea Therapeutics Inc. | Open-market purchase | +6,029 | $3.68 | $22,187 |
| Jun 6, 2023 | Aprea Therapeutics Inc. | Open-market purchase | +4,068 | $3.63 | $14,767 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.